Crossmark

Unraveling the structure–activity relationships of organometallic ferrocene-pyrazole and ferrocene-pyrimidine curcumin analogues in amyloid-β aggregation and glioblastoma treatment

Crossref DOI link: https://doi.org/10.1038/s41598-025-23467-0

Published Online: 2025-11-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kovač, Veronika

Huntosova, Veronika

Fedorova, Viktoria

Georgiou, Nikitas

Lai, Jian-Zong

Chien, Fan-Ching

Chen, Shean-Jen

Dolenec, Filip

Siposova, Katarina
Funding

Funding for this research was provided by:

Hrvatska Zaklada za Znanost (HRZZ-IP-2020-02-9162)

NextGenerationEU (No. 09-I02-03-V01-00021)

Slovenská Akadémia Vied (SAS-NSTC-JRP-2024-03_SUPRA-SIGHT)

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (2/0034/22)

European Union’s Horizon 2020 Research and Innovation programme (No.101007642; PhytoApp)
License Information

Text and Data Mining valid from 2025-11-13

Version of Record valid from 2025-11-13
More Information

Article History

Received: 10 July 2025

Accepted: 7 October 2025

First Online: 13 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below